39 results
8-K
EX-1.1
APLS
Apellis Pharmaceuticals Inc
1 Nov 23
Entry into a Material Definitive Agreement
7:59am
to represent the indemnified party would present such counsel with a conflict of interest, (ii) the actual or potential defendants in, or targets
8-K
EX-1.1
b5e2bbikvch3oo
24 Mar 22
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8:18pm
424B5
r1k1cp6bhfayj11s
24 Mar 22
Prospectus supplement for primary offering
8:02pm
424B5
23zzb35m
23 Mar 22
Prospectus supplement for primary offering
5:14pm
8-K
EX-1.1
weds2ow
20 Jan 22
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.1
lncspuit9jc4k
17 Nov 21
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
9:04am